SMMT

Summit Therapeutics PLC (SMMT)

US
$ 23.465-36.03%

Price Chart

Key Statistics

Market Cap
$ 17.42B
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
24.15M
52W High
$ 36.91
52W Low
$ 2.10
Dividend Yield
0.00%
Beta
-0.46

Technicals

50-Day MA
21.1343
200-Day MA
18.7018
52 Week High
36.91
52 Week Low
2.1

About SMMT

Summit Therapeutics Inc., a biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies.

Employees
159
Headquarters
Miami, FL
CEO
Dr. Mahkam Zanganeh D.D.S., M.B.A.

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Gainers

Symbol/Name
LTP
% Chg

Top Losers

Symbol/Name
LTP
% Chg